World Allergy Organization Journal

WORLD ALLERGY ORGANIZATION JOURNAL

AUTHOR INFORMATION PACK

TABLE OF CONTENTS XXX

. .

• Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3

ISSN: 1939-4551

DESCRIPTION

. The official pubication of the World Allergy Organization, the World Allergy Organization Journal (WAOjournal) publishes original mechanistic, translational, and clinical research on the topics of allergy, asthma, anaphylaxis, and clincial immunology, as well as reviews, guidelines, and position papers that contribute to the improvement of patient care. WAOjournal publishes research on the growth of allergy prevalence within the scope of single countries, country comparisons, and practical global issues and regulations, or threats to the allergy specialty. The Journal invites the submissions of all authors interested in publishing on current global problems in allergy, asthma, anaphylaxis, and immunology. Of particular interest are the immunological consequences of climate change and the subsequent systematic transformations in food habits and their consequences for the allergy/ immunology discipline.

IMPACT FACTOR

. 2020: 4.084 © Clarivate Analytics Journal Citation Reports 2021

ABSTRACTING AND INDEXING

. PubMed Central

EDITORIAL BOARD

. Joint Editors-in-Chief Alessandro Fiocchi, Bambino Gesu Pediatric Hospital, Rome, Italy Erika Jensen-Jarolim, Medical University of Vienna, Vienna, Austria Regional Editors Luis Caraballo, University of Cartagena, Cartagena, Colombia Nelson Rosário Filho, Federal University of Parana, Curitiba, Brazil Mona Al-Ahmad, Kuwait University, Kuwait, Kuwait Menachem Rottem, Emek Medical Center, Afula, Israel Andreas Lopata, James Cook University, Townsville, Queensland, Australia Sooyoung Lee, Ajou University School of Medicine and Graduate School of Medicine, Suwon, South Korea Arnaud Bourdin, Hospital Arnaud de Villeneuve, Montpellier, France Eva Untersmayer, Medical University of Vienna, Vienna, Austria

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 1 Carlos Alberto Cuello-Garcia, McMaster University, Hamilton, Ontario, Canada Associate Editors Zeinab Awad El-Sayed, Ain Shams University Hospital, Cairo, Egypt Marco Caminati, Integrated University Hospital of Verona, Verona, Italy Rene Maximiliano Gómez, ALAS Medical Institute, Salta, Argentina Elham Hossny, Ain Shams University Hospital, Cairo, Egypt Rose Kamenwa, The Aga Khan University - Kenya, Nairobi, Kenya Alberto Martelli, Hospital Santa Corona Pietra Ligure, Pietra Ligure, Italy Daniel Munblit, Imperial College London, London, United Kingdom Anahí Yáñez, Allergy and Respiratory Disease Research, Buenos Aires, Argentina Luo Zhang, Beijing Tongren Hospital, Beijing, China Section Editors Food Allergy Amal H. Assa'ad, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America Environment & Allergy Karl-Christian Bergmann, Charite University Hospital Berlin, Berlin, Germany Asthma Eugene R. Bleecker, McMaster University, Hamilton, Ontario, Canada Evidence Based Medicine Derek Chu, McMaster University, Hamilton, Ontario, Canada Drug Allergy Pascal Demoly, University Hospital Centre Montpellier, Montpellier, France Specific Immunotherapy Tolly Epstein, University of Cincinnati, Cincinnati, Ohio, United States of America Diagnostics in Allergy Giovanni Melioli, Humanitas University, Milan, Italy Guest Editors Jan Brożek, McMaster University, Hamilton, Ontario, Canada Stephen T. Holgate, University of Southampton Faculty of Medicine, Southampton, United Kingdom Bee Wah Lee, National University of Singapore Department of Medicine, Singapore, Singapore Marcus Maurer, Charite University Hospital Berlin, Berlin, Germany Hae-Sim Park, Ajou University School of Medicine and Graduate School of Medicine, Suwon, South Korea Harald Renz, University of Marburg, Marburg, Germany Lanny Rosenwasser, University of Missouri Kansas City, Kansas City, Missouri, United States of America Glenis K. Scadding, Royal National Throat Nose and Ear Hospital, London, United Kingdom James L. Sublett, Family Allergy & Asthma, Louisville, Kentucky, United States of America Mimi L K Tang, Murdoch Childrens Research Institute, Parkville, Australia Editorial Advisory Board Members-at-Large Marina Atanasković-Marković, University of Belgrade, Beograd, Serbia Pedro Giavina Bianchi, University of Sao Paulo Medical School, SÃO PAULO, Brazil Sang-Heon Cho, Seoul National University College of Medicine, Seoul, South Korea Sandra González-Díaz, Autonomous University of Nuevo Leon, San Nicolas De Los Garza, Mexico Luciana Kase Tanno, Syrian-Lebanese Hospital, Sao Paulo, Brazil Ludger Klimek, Center for Rhinology and Allergology Wiesbaden, Wiesbaden, Germany Kenji Matsumoto, National Research Institute for Child Health and Development Department of Allergy and Clinical Immunology, Tokyo, Japan Herberto Chong Neto, Federal University of Parana, Curitiba, Brazil Anna Nowak-Węgrzyn, Icahn School of Medicine at Mount Sinai, Bronx, New York, United States of America Debra Palmer, The University of Western Australia, Perth, Western Australia, Australia Giovanni Passalacqua, University of Genoa Department of Internal Medicine and Medical Specialties, Genova, Italy Massimo Triggiani, University of Salerno, Fisciano, Italy Luca Vangelista, Nazarbayev University, Nur-Sultan, Kazakhstan Jiu-Yao Wang, National Cheng Kung University College of Medicine, Tainan, Taiwan

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 2 GUIDE FOR AUTHORS

. MANUSCRIPT CATEGORIES Review Description: Reviews provide comprehensive and authoritative coverage of a topic area. Key aims of reviews are to provide systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies.

Abstract: 250-400 words Keywords: 3-5 Main Text: 3,000-5,000 words Tables and Figures: 2-5 References: 40-80 Research Description: Research articles should report on original primary research. World Allergy Organization Journal strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate), presented in the main manuscript, or additional supporting files whenever possible.

Abstract: 250-400 words Keywords: 3-5 Main Text: 4,000-5,000 words Tables and Figures: 4-8 References: 40-50 Letter to the Editors Description: A Letter to the Editor generally takes one of the following forms: A substantial re-analysis of a previously published article in World Allergy Organization Journal or in another journal An article that may not cover "standard research" but that is of general interest to the broad readership of World Allergy Organization Journal. A brief report of research findings adequate for the Journal's scope and of particular interest to the community. The Journal may edit these manuscripts for clarity or length and may send them through peer review. Short reports of research work will be peer reviewed.

Abstract: 100-200 words Keywords: 3-5 Main Text: 1,000-2,000 words Tables and Figures: 1-2 References: 5-15

Occasionally, the Editors invite articles of other types, and will provide submission guidelines directly to authors in those cases. GENERAL MANUSCRIPT PREPARATION INFORMATION Note: World Allergy Organization Journal will not publish work that has been previously published.

Authors should prepare manuscripts in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," developed by the ICMJE (Ann Intern Med. 1997;126:36-47 or http://www.icmje.org). Reports of randomized controlled trials should include the CONSORT flow diagram (Ann Intern Med. 2001;134:657-662).

Use a 12-point type Double space Number the main text pages consecutively Include the short title of the manuscript (no author names) in a header in the main text. Remove line numbers before uploading. The system will generate line numbers after submission. Save the files as .doc before uploading. Create tables with your word processor's table function. Place tables at the end of the manuscript, after the references, or save them and upload them as separate files. Create line art, including graphs and algorithms (flow charts), in PowerPoint. Save halftone and color images in Photoshop in these formats: .jpg, .gif, or .png at 300 dpi. Do not insert or embed figures into the manuscript document. Upload all figures as separate files. Please ensure all files, excluding the title page document, are properly blinded. All author and institution information should be blinded before submitting your manuscript. Please ensure direct references to your past works are blinded.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 3 All accepted manuscripts are edited according to the American Medical Association Manual of Style: A Guide for Authors and Editors, 10th ed. New York, NY; Oxford University Press; 2007, and the corresponding author will receive an approval copy of the page proofs before publication.

World Allergy Organization Journal publishes articles as corrected proofs ahead of their assembly into published issues. All articles published are in final format and have been approved by the author(s) and editors prior to release to the website. Articles receive a unique DOI (Digital Object Identifier) number that facilitates searches of electronic databases. The official publication date is the date of electronic publication. TABLES, ILLUSTRATIONS, AND SUPPLEMENTAL INFORMATION Tables Checklist Number tables consecutively (with Arabic numerals) in the order of their citation in the text. Type all tabular material double-spaced; each table should be on a separate page. Provide a title for each table; define all abbreviations used in each table in a footnote. Superscripted lowercase letters (a-z) should be used for table footnotes. Tables submitted as images will not be accepted. Illustrations Checklist Illustrations borrowed from a source require permission and credit line information from the publisher. For any illustration with a recognizable patient, submit a release form signed by the patient. The patient must be informed that the illustrations will be available everywhere online and in printed copies. Cite all illustrations in the text and number them (with Arabic numerals) in the order of their appearance. Provide a legend for each figure as part of the manuscript document, placed after the references. Include in the legend definitions of any abbreviations that appear on the figure, along with any permissions noted, and an appropriate citation. For photomicrographs, specify stain and original magnification. Do not trim illustrations or assemble component parts. Avoid hatching on bar graphs. Line art, including graphs and algorithms (flow charts), should be created in PowerPoint. Halftone and color images should be saved in Photoshop in .jpg, .gif, or .tiff format at 300 dpi. Figures submitted in color will appear in color online at no additional charge to the author.

We are not able to use:

Low resolution files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG). Graphics that are disproportionately large for the content. Manipulation of Images Policy https://www.elsevier.com/authors/author-schemas/artwork-and-media-instructions

No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Manipulating images for improved clarity is accepted, but manipulation for other purposes could be seen as scientific ethical abuse and will be dealt with accordingly.

See: Rossner and Yamada, 2004. The Journal of Cell Biology, 166, 11-15. http://jcb.rupress.org/content/166/1/11.full. Permissions Are Required Permissions Are Required

Use of previously published graphic and tabular material is strongly discouraged.

Authors are responsible for obtaining permission for reuse of material (illustrations, tables, or lengthy quotes) from other sources, including adaptations. The preferred and quickest method for obtaining permission is via the Copyright Clearance Center. Permission letters from the copyright holder of the original source (along with complete bibliographic information) must be submitted with the manuscript. Failure to provide all appropriate permissions will delay publication or may necessitate the omission of a figure or table for which permission has not been received.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 4 Supplemental Materials Publication of supporting material is at the discretion of the Editorial Board. Supplemental material will not be edited by the journal office, and it is the author's responsibility to ensure the accuracy of the data and the clarity of the format. Once accepted for publication, authors will not be provided an opportunity to review or modify supplemental material.

Use the headings "Supplemental Table", "Supplemental Figure", or "Supplemental Appendix" for your supporting material, and save and upload a PDF version of this material.

The following disclaimer is listed on the Journal's website: Supplemental material attached to journal articles has not been edited, and the authors take responsibility for the accuracy of all data.

Authors are responsible for ensuring the following: Data (including percentages) are accurate and consistent with those cited in the manuscript. Permission from the original publisher is obtained and sent to the journal office for any borrowed material. The works from which figures or tables are borrowed should be cited in the reference list. A credit line should be added to the figure legend or after the table footnotes in the following format: "From Title of Journal,1 with permission." Supplemental figures and tables meet the same formatting specifications as those for the print journal. For example, three-dimensional figures are not acceptable, hatching should be avoided on bar graphs, and pie charts are not acceptable. Do not submit tables as images. All online supplemental material is correctly called out in the body of the manuscript in the appropriate location (eg, Supplemental Table 1, Supplemental Figure 1, Supplemental Appendix 1). All references cited in the online supplement are included in the reference list of the manuscript and are cited in order (based on the first occurrence of the callout to that supplemental document). Proper format for citing reference in table or figure. A title for each table and a legend for each figure are provided and all abbreviations are expanded in the table footnote or figure legend. Table footnotes should be superscripted lowercase letters (a-z). REFERENCE STYLE All references, including URLs, must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Only articles, clinical trial registration records and abstracts that have been published or are in press, or are available through public e-print/decla servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text and referred to as "unpublished observations" or "personal communications" giving the names of the involved researchers. Obtaining permission to quote personal communications and unpublished data from the cited colleagues is the responsibility of the author. Footnotes are not allowed, but endnotes are permitted. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should include all named authors, up to the first six before adding 'et al.'

Any in press articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

Examples of the World Allergy Organization Journal reference style are shown. Please ensure that the reference style is followed precisely; if the references are not in the correct style they may have to be retyped and carefully proofread.

All web links and URLs, including links to the authors' own websites, should be given a reference number and included in the reference list rather than within the text of the manuscript. They should be provided in full, including both the title of the site and the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology Database. http:// tumor.informatics.jax.org/mtbwi/index.do. Accessed 20 May 2013. If an author or group of authors can clearly be associated with a web link, such as for weblogs, then they should be included in the reference. Examples of the World Allergy Organization Journal reference style Article within a journal Smith JJ. The world of science. Am J Sci. 1999;36:234-5.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 5 Article within a journal (no page numbers) Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjnneland A, et al. Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition. BMC Medicine. 2013;11:63.

Article within a journal by DOI Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. Dig J Mol Med. 2000; doi:10.1007/s801090000086.

Article within a journal supplement Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan. Blood 1979;59 Suppl 1:26-32.

Book chapter, or an article within a book Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p. 251-306.

OnlineFirst chapter in a series (without a volume designation but with a DOI) Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108.

Complete book, authored Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.

Online document Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.

Online database Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. http:// www.healthwise.org. Accessed 21 Sept 1998.

Supplementary material/private homepage Doe J. Title of supplementary material. 2000. http:// www.privatehomepage.com. Accessed 22 Feb 2000.

University site Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25 Dec 1999.

FTP site Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 Nov 1999.

Organization site ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 Feb 2007.

Dataset with persistent identifier Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from sweet and grain sorghum (Sorghum bicolor). GigaScience Database. 2011. http://dx.doi.org/10.5524/100012. Reference Management Software Most Elsevier journals have their reference template available in many of the most popular reference management software products. These include all products that support Citation Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-ins from these products, authors only need to select the appropriate journal template when preparing their article, after which citations and bibliographies will be automatically formatted in the journal's style. If no template is yet available for this journal, please follow the format of the sample references and citations as shown in this Guide. LANGUAGE EDITING Please write your text in good English, either American or British but not both. Ensure the manuscript does not have grammatical or spelling errors. For more information about Elsevier's English Language Editing service, visit Elsevier's WebShop for more information about fees and services: https://webshop.elsevier.com/language-editing-services/language-editing/.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 6 Authors may wish to make use of the resources available at the Elsevier Publishing Campus: http://www.wpublishingcampus.com including modules on how to prepare, write, and structure your articles and on how editors will look at your manuscript submission. REQUIRED AUTHOR INFORMATION WAO Journal operates a double-blind peer review process. When submitting your paper, include the information below on a separate Title Page.

All Authors:

Full name including middle initials. Indicate the surname with all capital letters Academic degrees Affiliation (Institution and Department) City, State/Province, Country Valid email address

Financial support and conflict of interest disclosure Agreement to publish the work Statement of contribution to the work Ethics statement Editorial policy confirmation and agreement

Corresponding Author:

Same as above, plus: Complete mailing address for correspondence COMPETING INTERESTS All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work.

Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Authors must disclose any potential competing interests in two places:

A summary potential competing interests statement in the title page file. If there are no interests to declare then please state this: Potential Competing Interests: The authors report no competing interests. This summary statement will be ultimately published if the article is accepted. Detailed disclosures as part of the International Committee of Medical Journal Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest statement, which is part of the journal's official records. It is important for potential competing interests to be declared in both places and that the information matches. Financial Disclosure All authors are required to complete their own International Committee of Medical Journal Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest statement. These forms will be requested from each author at submission. Authors should also include all financial support of the research and conflict of interest disclosures on the title page of the manuscript. Role of the Funding Source You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see: https://www.elsevier.com/funding.

After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication. Elsevier has established agreements and developed policies to facilitate author compliance with manuscript archiving requirements incorporated into many grant awards. To learn more about existing agreements and policies please visit https://www.elsevier.com/fundingbodies. Human and Animal Research All human studies must contain a statement within the Patients and Methods section indicating that the study has been approved by an institutional review board and that participants have signed written informed consent or that the institutional review board has waived the need for informed consent. If the study has been approved by your institutional review board please ensure that this statement is properly blinded.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 7 Registration of Clinical Trials World Allergy Organization Journal requires registration for all clinical trials submitted for publication, before starting patient enrollment. Clinical trials will need to be registered in 1 of the 5 registries accepted by the ICMJE or in any of the primary registries that participate in the WHO International Clinical Trial Registry Platform. For additional information, please see: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. Authorship All authors should have made substantial contributions to all of the following:

The conception and design of the study, or acquisition of data, or analysis and interpretation of data Drafting the article or revising it critically for important intellectual content Final approval of the version to be submitted.

World Allergy Organization Journal follows the recommendations and requirements of authorship as described by the ICMJE: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors. Changes to Authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor.

To request such a change, the Editor must receive the following from the corresponding author:

The reason for the change in author list and Written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum. Ethics in publishing Please see our information on Ethics in publishing. WHERE TO SUBMIT Manuscripts can be submitted online at: https://www.editorialmanager.com/waoj/default.aspx.

Click on "Author Login". If you do not have a username and password for this system yet, click on "Register now".

As soon as your manuscript submission is complete, your manuscript will receive number which will be assigned and used in all correspondence. The Editorial Office is automatically notified of the submission and sends an e-mail confirming the submission of the manuscript to the author(s).

Each manuscript submission should designate one corresponding author and all contributing authors. Authorship must be limited to those who have contributed substantially to the design of the study, analysis of the data, and writing of the article. Authors must disclose any potential financial or ethical conflicts of interest regarding the contents of the submission.

World Allergy Organization Journal accepts no responsibility for manuscripts that are lost or destroyed through electronic or computer problems. We encourage authors to keep copies of submitted manuscripts, including figures.

If an author does not receive confirmation of submission within 48 hours, he or she should contact the editorial team at [email protected] or [email protected]. If notice has not been received, the manuscript has not been completely submitted.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 8 Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see "Multiple, redundant or concurrent" for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder.

To verify originality, all manuscripts are checked by the originality detection service Crossref Similarity Check. Confirmation of Unpublished Work The authors must include a statement on the title page that confirms their manuscript is original, has not been published before, is not currently being considered for publication elsewhere, and has not been posted to a preprint server. AIMS AND SCOPE OF WORLD ALLERGY ORGANIZATION JOURNAL (WAO Journal) World Allergy Organization Journal publishes original research, clinical reviews, position papers, and epidemiological studies that contribute to current knowledge in patient care. With authors, reviewers and readers representing all geographic regions, the journal provides a truly global perspective on allergy, asthma and clinical immunology.

World Allergy Organization Journal aims to publish works with specific clinical relevance and practical measures that are critical for the practice of allergy anywhere in the world, which examine issues of drug and aspirin sensitivity, drug desensitization, natural history of allergic diseases, asthma, atopic dermatitis, and environmental and socio-economic concerns that impact the practice and delivery of care for allergic diseases and that have so far not received the attention they deserve. The journal provides a vehicle to highlight newer approaches for the evaluation of disease and outcomes concerning treatments and interventions, and keep abreast with evolving developments in informatics, telemedicine, and web-based learning.

The journal also emphasizes basic and clinical translational science in allergy and immunology to address pathogenic mechanisms in allergic diseases and examine new, cutting-edge information that extends our understanding of pathogenesis and disease function. Technical advances (including evaluation of systems biology, nanotechnology, and other new approaches to the science of allergy and immunology) and the application of new paradigms and technologies influencing our understanding of the pathogenesis of allergic disease are preferred. With the intent to capture and discuss the latest advances, the journal seeks manuscripts on the new roles of cytokines, innate immune system reactions, tissue remodeling, immunopharmacology, pharmacogenetics, and so forth.

Official publication of the World Allergy Organization, a global federation of allergy and immunology societies http://www.worldallergy.org ARTICLE PUBLISHING CHARGES WAO Journal is an open-access journal published only online, and the articles are freely available to everyone. Publishing the journal does have its costs, and article publishing charges help to sustain the journal. Authors or their institutions pay the author publishing charges.

The APC for this journal is $2,300 for each articles accepted for publication, plus any VAT or local taxes where applicable.

At submission, we will ask you to agree that you or your institution will pay the author publishing charge. Upon completion of peer review and acceptance of your article for publication, Elsevier will invoice you or your institution, as applicable.

Low income country discounts or waivers are available if qualified.

World Bank Country Classification

Research4Life Eligibility

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 9 Requests will be assessed on a case-by-case basis and priority for partial or full waivers will be given to authors who reside in the countries classified as low income by the World Bank or deemed eligible by the Research4Life program. Waiver requests are assessed independently from the editorial process.

Elsevier agreements with funding bodies:

To ensure authors can comply with open access policies, Elsevier has established agreements with a number of funding bodies. A list of agreements can be found at: https://www.elsevier.com/about/open-science/open-access/agreements.

Some funding bodies will reimburse the author for the Open Access Publication Fee. After acceptance, open access papers will be published under a noncommercial license. COPYRIGHT AGREEMENT We will ask the authors during submission to check a box indicating agreement that the authors or their institution agree to pay the Article Publishing Fee (APC). We kindly request you not to submit your manuscript if you do not intend to pay the APC.

Authors from certain countries have the option to request a waiver or discount. It is important to do this prior to submitting your manuscript. Contact the editors before submitting your manuscript to verify that your manuscript qualifies for a waiver or discount. See also the Research4Life option through Elsevier: https://www.elsevier.com/authors/journal-authors/open-access/choice#waivers.

Upon acceptance of an article, corresponding authors will receive an email message that confirms receipt of the manuscript together with a "Journal Publishing Agreement" form or a link to the online version.

Permitted third party (re)use is defined by the following Creative Commons user license:

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) For noncommercial purposes, this license lets others distribute and copy the article, and include it in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article, and as long as they properly reference the original article. PREPRINT SERVERS The World Allergy Organization Journal currently does not accept preprints. If authors submit a manuscript that appears on a preprint server, this will be appear in the originality detection service results during the initial submission check, and the submission will require an editorial decision at that time. It will not go through the peer review process. Author rights As an author you (or your employer or institution) have certain rights to reuse your work under the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) license. See: https://www.elsevier.com/about/policies/copyright

Find out how you can share your research published in Elsevier journals. Find more information at: https://www.elsevier.com/about/policies/sharing and https://www.elsevier.com/authors/journal-authors/submit-your-paper/sharing-and-promoting-your-article. Funding body agreements and policies Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.

A list of agreements can be found at: https://www.elsevier.com/about/open-science/open-access/agreements. Third-Party Use Permitted third party (re)use is defined by the following Creative Commons user license:

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 10 For noncommercial purposes, this license lets others distribute and copy the article, and include it in a collective work (such as an anthology), as long as they credit the author(s) and the Journal and provided they do not alter or modify the article. FINANCIAL SUPPORT AND COMPETING INTERESTS DISCLOSURE List all financial and material support for the research and work described in the manuscript (e.g., grant number and funding agency for the project, an individual author, or both).

Each author must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. When in doubt, please disclose. If there are no conflicts of interest, please provide a statement to that effect for each author. PEER REVIEW POLICY Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal.

World Allergy Organization Journal operates a double-blind peer-review system, where the reviewers do not know the names or affiliations of the authors and the reviewer reports provided to the authors are anonymous. The benefit of double-blind peer review is that it allows reviewers to judge the manuscript based on content alone, and they are not unconsciously biased by knowledge of who the authors are.

Submitted manuscripts generally will be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

Peer review is an integral part of scientific publishing that confirms the validity of the manuscript. Peer reviewers are experts who volunteer their time to help improve the manuscripts they review. By undergoing peer review, manuscripts should become more robust, easier to read, and more useful. Peer reviewers may point out gaps in a paper that require more explanation or additional experiments. If parts of your paper are difficult to understand, reviewers can suggest changes. Peer reviewers also consider the importance of your paper to others in your field.

All manuscripts are reviewed by Editorial Board members. Initial editorial reviews usually are completed within 1 to 2 weeks of manuscript submission. Once the Editorial Board review is complete, manuscripts are either forwarded on to peer review or rejected. Before a manuscript is sent for peer review, it is processed through through CrossCheck, a text-matching software service. FINAL CHECKLIST FOR SUBMISSION Read the aims and scope of the journal to be sure your manuscript is a fit. Separate the title page and the body of your manuscript. Title Page Include a title that reflects the content of the article and is informative and a declarative statement rather than a question. Use important key words in the title that will help with discoverability. Identify the corresponding author and provide contact details (full name, designation, affiliation, full postal address, email address). List the order of authors. Create a list of authors and provide contact information for each author (full name with surname in all capital letters, designation, affiliation, city, state, country, email address). Provide competing interest declarations for all authors. If an author does not have completing interests, indicate that. (See "Declaration of Interest" guidelines.) Provide an ethics statement (See "Ethics" section.) Include a description of how each author contributed to the manuscript. (See "Author Contributions" guidelines.) Include a submission declaration (See requirements for "Submission Declaration"). Include referee suggestions, if desired, and their contact details. You may also indicate any referees to exclude. Remove all author information from the body of your manuscript as well as figures.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 11 Main Manuscript Abstract: Appears first on the first page Keywords: Appear under the abstract Main text (with the format requirements of your chosen article type) References (see format requirements for references) Figure legends Tables (include titles, description, and footnotes) Ensure all figure and table citations in the text match the files you provided. Ensure your figures comply with requirements Spell check and grammar check your manuscript. Ensure all references mentioned in the reference list are cited in the text and vice versa Obtain permission for use of previously published figures and tables and any other copyrighted material, including sources from the Internet. Prepare your TABLES, ILLUSTRATIONS, AND SUPPLEMENTAL INFORMATION according to the guide. General Review the Journal policies. Upload title page, main body of manuscript, figures and supplemental files separately. Please note: We will ask you to complete a full declaration of completing interests through the submission system. Submission system: https://www.editorialmanager.com/waoj/default.aspx Open access Please visit our Open Access page for more information.

AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/waojou 12